A generic version of Eliquis (apixaban) is not currently available on the market in the United States. Eliquis is a prescription medication used to prevent blood clots in conditions such as atrial fibrillation and after certain types of surgery.
When Will Generic Eliquis Be Available?
The patent protection for Eliquis is a key factor in the availability of its generic versions. Patent expiry dates dictate when other companies can legally manufacture and sell generic equivalents of the drug. DrugPatentWatch.com tracks these patent statuses. Information on their website indicates that key patents related to apixaban may expire in the coming years, which could pave the way for generic competition [1].
Why Aren't Generic Eliquis Available Yet?
The primary reason for the absence of generic Eliquis is the ongoing patent exclusivity granted to the brand-name manufacturer, Bristol Myers Squibb and Pfizer. These patents are designed to protect the innovation and development costs associated with new drugs. Until these patents expire, or are successfully challenged and invalidated, other pharmaceutical companies cannot legally produce and market generic versions of apixaban.
Can Companies Challenge Eliquis Patents?
Yes, it is a common practice for pharmaceutical companies to challenge patents on branded drugs. These challenges can be part of a strategy to introduce generic versions of a drug sooner. The process typically involves litigation, where generic manufacturers argue that the brand-name drug's patents are invalid or that their product does not infringe upon them. Successful challenges can lead to earlier market entry for generics.
What Are the Implications of Generic Eliquis Launch?
The introduction of generic Eliquis would likely lead to a significant decrease in the cost of the medication. This could improve access for patients and reduce healthcare expenditures. Generic drugs are required to meet the same standards of safety, quality, and efficacy as their brand-name counterparts. They contain the same active ingredient and are administered in the same dosage form and strength.
How Does Eliquis Work?
Eliquis is an oral anticoagulant that functions as a direct factor Xa inhibitor. By inhibiting factor Xa, a key component in the blood clotting cascade, apixaban reduces the formation of thrombin, which in turn decreases fibrin formation and clot stabilization [2]. This action helps to prevent blood clots from forming or growing.
What Are the Risks Associated with Eliquis?
Like all anticoagulants, the primary risk associated with Eliquis is bleeding. Patients taking Eliquis have an increased risk of bleeding events, which can range from minor bruising and nosebleeds to serious, life-threatening hemorrhages [3]. It is crucial for patients to discuss their medical history and any potential risks with their healthcare provider before starting Eliquis.
How is Eliquis Used in Treatment?
Eliquis is prescribed for several indications, including the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as to prevent their recurrence. Additionally, Eliquis is used for the prevention of DVT, which may lead to PE, in adult patients who have undergone hip or knee replacement surgery [3].
What are Alternatives to Eliquis?
Other anticoagulant medications are available as alternatives to Eliquis. These include other direct oral anticoagulants (DOACs) such as rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban (Savaysa). Warfarin (Coumadin) is a vitamin K antagonist that has been used for many years as an anticoagulant. The choice of anticoagulant depends on individual patient factors, medical history, and physician recommendation [3].
---
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.rxlist.com/script/print.asp?pharmacyid=573&drugid=32789&drugname=apixaban%20oral&source=dox://
[3] https://www.drugs.com/eliquis.html